Ophthalmic compositions for treating ocular hypertension

Details for Australian Patent Application No. 2003245565 (hide)

Owner Merck & Co., Inc. Banyu Pharmaceutical Co., Ltd.

Inventors Ogidigben, Miller J.; Yamakawa, Takeru; Sagara, Yufu

Agent Spruson & Ferguson

Pub. Number AU-B-2003245565

PCT Number PCT/US03/19263

PCT Pub. Number WO2003/105781

Priority 60/389,220 17.06.02 US

Filing date 17 June 2003

Wipo publication date 31 December 2003

Acceptance publication date 3 January 2008

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 31/4545 (2006.01)

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 27/06 (2006.01) Drugs for disorders of the senses

C07D 235/26 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 271/107 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

25 September 2003 Complete Application Filed

  Priority application(s): 60/389,220 17.06.02 US

26 February 2004 Application Open to Public Inspection

  Published as AU-B-2003245565

3 January 2008 Application Accepted

  Published as AU-B-2003245565

1 May 2008 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the copatentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003245566-VISUAL PRESENTATION OF INFORMATION IN MULTIPLE DIMENSIONS

2003245564-METHOD AND ARRANGEMENT OF ROTATING MAGNETICALLY INDUCIBLE PARTICLES